UBB-2000

N/A

Report date: 2025/03/25 16:00:21
NME

Base Information

Drug NameUBB-2000
Drug Alias NameUBB-2000
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTEK receptor tyrosine kinase agonists
TargetsTEK receptor tyrosine kinase
Therapy Area/IndicationsDiabetic macular oedemaMacular DegenerationDiabetic Retinopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUnity Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesUnity Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaMacular DegenerationDiabetic Retinopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A